País: Nova Zelanda
Idioma: anglès
Font: Medsafe (Medicines Safety Authority)
Progesterone 200mg; ; Progesterone 200mg; Progesterone 200mg
Pharmaco (NZ) Ltd
Progesterone 200 mg
200 mg
Capsule
Active: Progesterone 200mg Excipient: Gelatin Glycerol Purified water Soya oil Sunflower oil Titanium dioxide Active: Progesterone 200mg Excipient: Gelatin Glycerol Purified water Soya oil Sunflower oil Titanium dioxide Active: Progesterone 200mg Excipient: Gelatin Glycerol Purified water Soya oil Sunflower oil Titanium dioxide
Prescription
Changzhou Jiaerke Pharmaceuticals Group Corp Ltd
Oral Route: Hormone replacement therapy - Adjunctive use with an oestrogen in postmenopausal women with an intact uterus (for hormone replacement therapy [HRT]). Vaginal Route: Luteal phase support - Supplementation of the luteal phase during Assisted Reproductive Technology (ART) cycles.
Package - Contents - Shelf Life: Blister pack, PVC/Aluminium or PVC/PVdC/Aluminium - 15 capsules - 36 months from date of manufacture stored at or below 30°C. Do not refrigerate. - Blister pack, PVC/Aluminium or PVC/PVdC/Aluminium - 42 capsules - 36 months from date of manufacture stored at or below 30°C. Do not refrigerate.
2015-02-16
UTROGESTAN 200 CMI 1 CONSUMER MEDICINE INFORMATION (CMI) SUMMARY 1. WHY AM I USING UTROGESTAN ? 2. WHAT SHOULD I KNOW BEFORE I USE UTROGESTAN? 3. WHAT IF I AM TAKING OTHER MEDICINES? 4. HOW DO I USE UTROGESTAN? 5. WHAT SHOULD I KNOW WHILE USING UTROGESTAN? 6. ARE THERE ANY SIDE EFFECTS? UTROGESTAN 200® The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. UTROGESTAN contains the active ingredient progesterone. UTROGESTAN is used for women who need extra progesterone while undergoing fertility treatment (e.g. ART). For more information, see Section 1. Why am I using UTROGESTAN? in the full CMI. Do not use if you have ever had an allergic reaction to UTROGESTAN or any of the ingredients listed at the end of the CMI. Do not use if you are breast-feeding. TALK TO YOUR DOCTOR IF YOU HAVE ANY OTHER MEDICAL CONDITIONS OR ARE TAKING ANY OTHER MEDICINES. For more information, see Section 2. What should I know before I use UTROGESTAN? in the full CMI. Some medicines may interfere with UTROGESTAN and affect how it works. A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI. • UTROGESTAN should be used as instructed by your doctor at the recommended dose and timeframes for each use. UTROGESTAN is intended to be inserted into the vagina. More instructions can be found in Section 4. How do I use UTROGESTAN? in the full CMI. THINGS YOU SHOULD DO • Remind any doctor, dentist or pharmacist you visit that you are using UTROGESTAN. • Follow all direction given to you by your doctor carefully. THINGS YOU SHOULD NOT DO • Do not use if you have unusual vaginal bleeding that has not been evaluated by your doctor, • Do not use if you have known missed abortions or ectopic pregnancy • Do not use if you have or are suspected of having cancer of the breast or genital tract • Do not use if you have a blood clot or bleeding on the brain. • Do not use if your liver is not working well. DRIVING OR USING MACHIN Llegiu el document complet
NEW ZEALAND DATA SHEET UTROGESTAN 200mg caps UTROGEST007 Aug 2023 Page 1 of 9 UTROGESTAN 200MG CAPSULES Progesterone 1 PRODUCT NAME UTROGESTAN 200MG CAPSULES 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Soft, ovoid, slightly yellow capsule containing a whitish oily suspension of 200 mg progesterone (micronised). Excipient(s) with known effect: Soya lecithin For full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Capsules, soft 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS UTROGESTAN 200 mg capsule is indicated in adults, _via_ the oral or vaginal route, for: ORAL ROUTE _HORMONE REPLACEMENT THERAPY _ • Adjunctive use with an oestrogen in postmenopausal women with an intact uterus (for hormone replacement therapy [HRT]) VAGINAL ROUTE _LUTEAL PHASE SUPPORT _ • Supplementation of the luteal phase during Assisted Reproductive Technology (ART) cycles 4.2 DOSE AND METHOD OF ADMINISTRATION _DOSAGE _ The recommended dose is as follows, according to the indication and the administration route: _ _ _ORAL ROUTE _ • _IN THE TREATMENT OF MENOPAUSE_: oestrogen alone therapy is not recommended on its own in menopausal women with an intact uterus. The usual dose is 200 mg/day at bedtime at least 12 to 14 days per month, i.e. on days 15 to 26 of each cycle or in the last 2 weeks of each treatment sequence of oestrogen therapy followed by approximately one week without any replacement therapy and during which withdrawal bleeding may occur. Alternatively 100 mg can be given at bedtime, from days 1 to 25 of each cycle, withdrawal bleeding being less with this treatment schedule. NEW ZEALAND DATA SHEET UTROGESTAN 200mg caps UTROGEST007 Aug 2023 Page 2 of 9 _VAGINAL ROUTE _ • _IN THE LUTEAL PHASE SUPPORT DURING ASSISTED REPRODUCTIVE TECHNOLOGY (ART_ )_: _ the recommended dosage is 600 mg/day, in three divided doses, from the evening after the day of oocyte retrieval or latest the day of embryo transfer until at least the 7 th week of pregnancy and not later than the 12 th week of pregnancy. _METHOD OF ADMINISTRATI Llegiu el document complet